ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 216 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.93 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $25,000 | +316.7% | 272 | +149.5% | 0.00% | – |
| Q3 2021 | $6,000 | -66.7% | 109 | -57.9% | 0.00% | – |
| Q2 2021 | $18,000 | -74.6% | 259 | -74.8% | 0.00% | -100.0% |
| Q1 2021 | $71,000 | +1.4% | 1,027 | +12.5% | 0.00% | 0.0% |
| Q4 2020 | $70,000 | 0.0% | 913 | -1.7% | 0.00% | 0.0% |
| Q3 2020 | $70,000 | +191.7% | 929 | +140.1% | 0.00% | – |
| Q2 2020 | $24,000 | +1100.0% | 387 | +867.5% | 0.00% | – |
| Q3 2019 | $2,000 | -60.0% | 40 | -50.0% | 0.00% | – |
| Q2 2019 | $5,000 | +25.0% | 80 | 0.0% | 0.00% | – |
| Q1 2019 | $4,000 | +33.3% | 80 | 0.0% | 0.00% | – |
| Q4 2018 | $3,000 | -25.0% | 80 | 0.0% | 0.00% | – |
| Q3 2018 | $4,000 | – | 80 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 139,528 | $6,083,000 | 4.46% |
| Eversept Partners, LP | 134,151 | $5,848,984 | 2.68% |
| DAFNA Capital Management LLC | 95,242 | $4,153,000 | 1.94% |
| GREAT POINT PARTNERS LLC | 302,000 | $13,167,000 | 1.82% |
| Atika Capital Management LLC | 190,000 | $8,284,000 | 1.59% |
| Crawford Lake Capital Management, LLC | 205,600 | $8,964,000 | 1.57% |
| Crawford Lake Capital Management, LLC | 205,688 | $8,968,000 | 1.57% |
| Cormorant Asset Management, LP | 450,000 | $19,620,000 | 1.45% |
| SENZAR ASSET MANAGEMENT, LLC | 11,123 | $485,000 | 1.40% |
| Rhenman & Partners Asset Management AB | 284,621 | $12,409,000 | 1.27% |